IMC-Chicago, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
IMC-Chicago, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,368,000
-79.0%
15,193
-78.4%
0.00%
-83.3%
Q3 2021$6,504,000
+577.5%
70,325
+469.7%
0.01%
+500.0%
Q2 2021$960,000
+9.5%
12,345
+4.9%
0.00%0.0%
Q1 2021$877,000
-38.0%
11,768
-0.8%
0.00%
-80.0%
Q1 2019$1,414,00011,8640.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders